BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1001284)

  • 1. Mephenytoin: a reappraisal.
    Troupin AS; Ojemann LM; Dodrill CB
    Epilepsia; 1976 Dec; 17(4):403-14. PubMed ID: 1001284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of mephenytoin and its metabolite, nirvanol, in epileptic patients.
    Theodore WH; Newmark ME; Desai BT; Kupferberg HJ; Penry JK; Porter RJ; Yonekawa WD
    Neurology; 1984 Aug; 34(8):1100-2. PubMed ID: 6431315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aplastic anemia caused by the hydantoin derivative mesantoin; fatal case].
    STOUSLAND H
    Tidsskr Nor Laegeforen; 1951 Jul; 71(13-14):428-9. PubMed ID: 14855463
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of 3-methyl-5-ethyl-5-phenylhydantoin (mephenytoin) to 5-ethyl-5-phenylhydantoin (Nirvanol) in mice in relation to anticonvulsant activity.
    Kupferberg HJ; Yonekawa W
    Drug Metab Dispos; 1975; 3(1):26-9. PubMed ID: 234831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity.
    Snead C; Siegel N; Hayslett J
    Pediatrics; 1976 Jan; 57(1):98-101. PubMed ID: 1246508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of mephenytoin (3-methyl-5-ethyl-5-phenylhydantoin) and its demethylated metabolite by selective ion monitoring.
    Yonekawa W; Kupferberg HJ
    J Chromatogr; 1979 Jun; 163(2):161-7. PubMed ID: 541367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis and therapy of complex partial seizures with barbiturates, hydantoins, and other drugs.
    Tassinari CA; Roger J
    Adv Neurol; 1975; 11():201-19. PubMed ID: 3105
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of mephenytoin and ethotoin.
    Troupin AS; Friel P; Lovely MP; Wilensky AJ
    Ann Neurol; 1979 Nov; 6(5):410-4. PubMed ID: 42344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients.
    Bourgeois BF; Küpfer A; Wad N; Egli M
    Epilepsia; 1986; 27(4):412-8. PubMed ID: 3720699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal aplastic anemia due to methylphenylethyl hydantoin (mesantoin).
    SPRING M; SOLTZ WB
    N Y State J Med; 1955 Dec; 55(23):3478-9. PubMed ID: 13272897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two fatal cases of aplastic anemia caused by mesantoin (methylphenylethyl hydantoin)].
    BENHAMOU E; ALBOU A
    Alger Medicale; 1952; 56(7):389-92. PubMed ID: 12996423
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal aplastic anemia associated with mesantoin; report of a case with autopsy.
    STILLMAN S; BEDELL SG; LEAVITT D
    J Fla Med Assoc; 1951 Feb; 37(8):496-7. PubMed ID: 14803665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
    Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
    Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aplastic anemia following mesantoin with recovery, case report.
    NIELSEN DI
    Ann West Med Surg; 1952 Sep; 6(9):562-3. PubMed ID: 12977085
    [No Abstract]   [Full Text] [Related]  

  • 15. Paradoxical intoxication--a complication of anticonvulsant administration.
    Troupin AS; Ojemann LM
    Epilepsia; 1975 Dec; 16(5):753-8. PubMed ID: 1222751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancytopenia following the use of mesantoin and thiantoin. Report of a fatal case.
    WEISS HA; HAWLEY WD
    U S Armed Forces Med J; 1951 Jan; 2(1):83-6. PubMed ID: 14798701
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative results in seizure control using phenobarbital, dilantin, and mesantoin.
    RUSKIN DB
    Am J Psychiatry; 1950 Dec; 107(6):415-21. PubMed ID: 14838144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypersensitivity reaction produced by the administration of mesantoin, which simulated Hodgkin's lymphoma].
    Romero García F; Reynaga Sánchez R; Wolburg López J
    Rev Invest Clin; 1967; 19(1):51-8. PubMed ID: 5317594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Another case of aplastic anemia due to mesantoin].
    WEINMANN O
    Wien Klin Wochenschr; 1951 Aug; 63(33):587-8. PubMed ID: 14877149
    [No Abstract]   [Full Text] [Related]  

  • 20. Two cases of fatal pancytopenia following mesantoin therapy.
    SWARTOUT R
    Calif Med; 1953 Feb; 78(2):138-9. PubMed ID: 13019614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.